Compound information
- Natural Products
- NACP109691
- Molecular Formula
- C21H30O4
- Molecular Weight
- 346.21440944 g/mol
- Structure
-
- IUPAC Name
- 1-(4-hydroxy-3-methoxy-phenyl)tetradec-1-ene-3,5-dione
- InChI
- InChI=1S/C21H30O4/c1-3-4-5-6-7-8-9-10-18(22)16-19(23)13-11-17-12-14-20(24)21(15-17)25-2/h11-15,24H,3-10,16H2,1-2H3
- InChI Key
- QJDGTTCAEQPSJA-UHFFFAOYSA-N
- SMILES
- O=C(C=CC1=CC=C(O)C(OC)=C1)CC(=O)CCCCCCCCC
- CAS
- 136826-50-1
- SuperClass
- Phenylpropanoids and polyketides
- Class
- Cinnamic acids and derivatives
- SubClass
- Hydroxycinnamic acids and derivatives
- Source
- CNP0296363
Warheads
- Carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 25 | Ring Count | 1 |
Heteroatom Count | 4 | Rotatable Bond Count | 13 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 63.6 Å2 | LogP | 4.844 |
LogS | -5.909 | LogD | 3.644 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.874 | Pgp substrate | 0.002 |
HIA | 0.969 | F20 % | 0.334 |
F30 % | 0.109 | Caco-2 | -4.739 |
MDCK | -4.577 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.997 | PPB | 40.673 |
VD | 0.794 | Fu | 1.391 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.908 | CYP1A2 substrate | 0.516 |
CYP2A6 substrate | 0.394 | CYP2B6 substrate | 0.629 |
CYP2C19 inhibitor | 0.341 | CYP2C19 substrate | 0.656 |
CYP2C8 substrate | 0.636 | CYP2C9 inhibitor | 0.54 |
CYP2C9 substrate | 0.014 | CYP2D6 inhibitor | 0.045 |
CYP2D6 substrate | 0.16 | CYP2E1 substrate | 0.377 |
CYP3A4 inhibitor | 0.383 | CYP3A4 substrate | 0.047 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.9 | CL | 8.629 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.627 | Hepatotoxicity | 0.213 |
Mutagenicity | 0.476 | Rat Oral Acute Toxicity | 0.295 |
FDAMDD | 0.403 | Skin Sensitization | 0.997 |
Carcinogenicity | 0.103 | Eye Corrosion | 0.004 |
Eye Irritation | 0.923 | Respiratory Toxicity | 0.831 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.536 | IGC50 | 5.746 |
LC50FM | 6.36 | LC50DM | 5.432 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.431 | NR-AR-LBD | 0.572 |
NR-AhR | 0.153 | NR-Aromatase | 0.303 |
NR-ER | 0.673 | NR-ER-LBD | 0.412 |
NR-PPAR-gamma | 0.881 | SR-ARE | 0.393 |
SR-ATAD5 | 0.66 | SR-HSE | 0.775 |
SR-MMP | 0.923 | SR-p53 | 0.589 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.